Clinical Update: Multmodal Perioperative Analgesia

Size: px
Start display at page:

Download "Clinical Update: Multmodal Perioperative Analgesia"

Transcription

1 Clinical Update: Multmodal Perioperative Analgesia by Kate O Hanlan, MD Review tissue damage cyclooxygenase cascade releasing pain transmitters. Discuss COX 1 inhibition and reduction of platelet aggregation, gastric mucosal integrity, and reduction of renal blood flow. Discuss COX 2 inhibition and reduction of pain, with coronary vasoconstriction. Understand the differences in risk profile between the two parenteral NSAID s. Explain the CNS efficacy of parenteral acetaminophen. Integrate the published evidence to write a multimodal analgesic regimen for your surgical patients. Tissue Injury Arachidonic Acid Tissue Injury COX-1(Constitutive) Prostaglandins GI Cytoprotection Platelet Function Renal Function NSAID s COX-2(Inducible) NSAID s Prostaglandins Inflammation Pain Fever GI Cytoprotection Platelet Function Renal Function Inflammation Pain Fever Prothrombotic Effects

2 Cyclooxengase 1 and 2 inhibitors: antipyretic and analgesic Ø COX-1- prostaglandin synthesis in response to stimulation by circulating hormones, as well as maintenance of normal renal function, gastric mucosal integrity, and platelet aggregation. Ø Cox -1 Selective inhibition bad for GI, good for heart. Ø COX-2: Released by IL-1, TNF, lipopolysaccharide, mitogens, and reactive oxygen intermediates in vasculature, Ø COX-2 Selective inhibition is good for GI. Potent antiinflammatory, no prostacyclin and a lot of thromboxane, so no good for CABG. Inhibition of COX-2 Relative to COX-1 COX-1 COX-2 Meloxicam Celecoxib Diclofenac Ibuprofen Ketorolac Naproxen Warner, TD et al, Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclooxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis. Proc Natl Acad Sci U S A June 22; 96(13): Pharmacology

3 NSAID s and platelet aggregation Aspirin strong inhibitory effect on platelet function, significantly reducing RBC aggregation. 1 Platelet effects of ketorolac were moderate, whereas ibuprofen had a minor impact on platelet function. 1 Ketorolac has increased COX-1 inhibition compared with naproxen and ibuprofen Bozzo et al. Prohemorrhagic potential of dipyrone, ibuprofen, ketorolac, and aspirin: mechanisms associated with blood flow and erythrocyte deformability. J Cardiovasc Pharmacol 2001 Aug;38(2): Uzan A. The unexpected side effects of new nonsteroidal anti-inflammatory drugs. Expert Opin Emerg Drugs 2005 Nov;10(4): NSAID s and UGI bleeds Systematic review of observational studies on NSAIDs and upper GI bleeding/perforation published between 2000 and Ibuprofen RRs was 2.69 [95% CI ]). 1 ketorolac RR was [95% CI ]). 1 More COX-1 inhibition associatied with more UGI bleeds. 1 Ibuprofen OR for UGI bleed was IV ketorolac OR for UGI bleed was Parenteral NSAIDs posed a higher risk, but celecoxib and ibuprofen posed a lower risk than other NSAIDs Masso et al. Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis Rheum 2010 Jun;62(6): Chang et al. Risk of hospitalization for upper gastrointestinal adverse events associated with nonsteroidal anti-inflammatory drugs: a nationwide case-crossover study in Taiwan. Pharmacoepidemiol Drug Saf 2011 Jul;20(7):

4 Determinants of UGI Bleeding RR 95% CI Age ( ) NSAID use 4.4 ( ) Multiple NSAIDs 7.8 ( ) Heavy Smoking 1.6 ( ) Antiulcer med 3.7 ( ) Ulcer (no complic) 5.3 ( ) Corticosteroids 1.6 ( ) Ø 81% of pts in ARAMIS study with serious GI complications had no prior GI symptoms. Risser et al. NSAID prescribing precautions. American family physician. Dec Masso Gonzalez et al. Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis Rheum. Jun Singh G. Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, Rheumatism, and Aging Medical Information System. Am J Ther. Mar IBU (gm/ml) IV IBU 5-7 Minute Infusion 800 mg IV Ibuprofen 800 mg PO Ibuprofen Time Post-dose (hours) Pavliv, L., B. Voss, et al. (2011). "Pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults." American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 68(1):

5 Pre-op IV Ibuprofen 319 women had elective abdominal hysterectomy received placebo or 800 IV IBU initiated intra-op and q 6h x 8 doses then q 6 h prn for 5 days. Also had morphine PCA pump or patient request. Narcotic use after 800 mg IV IBU First 24 hours at rest 21% First 24 hours with movement 14% Reduction in median narcotic use 19% Reduction in mean narcotic use 16% (P < 0.001) Kroll et al. A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen (i.v.-ibuprofen) in the management of postoperative pain following abdominal hysterectomy. Pain Pract. Jan-Feb 2011;11(1): IV IBU pre- and post-operatively Pain reduction Narcotic reduction Hysterectomy 1 19% 16% Joint rplcmt 2 32% 31% No significant difference bleeding adverse events, blood transfusions or other serious adverse events. More patients receiving IV ibuprofen experienced vomiting and more patients receiving placebo experienced dyspepsia. 1. Kroll PB, Meadows L, Rock A, Pavliv L. A multicenter, randomized, double-blind, placebocontrolled trial of intravenous ibuprofen (i.v.-ibuprofen) in the management of postoperative pain following abdominal hysterectomy. Pain Pract. Jan-Feb 2011;11(1): Singla N, Rock A, Pavliv L. A multi-center, randomized, double-blind placebo-controlled trial of intravenous-ibuprofen (IV-ibuprofen) for treatment of pain in post-operative orthopedic adult patients. Pain Med. Aug 2010;11(8):

6 Reduction in Pain Intensity Scores After Orthopedic Surgery 185 patients: knee or hip replacement, reconstruction, or arthroplasty Randomized: 800 IBU or placebo at induction, q6h x 5, prn q6h x 5d. Rescue with: morphine PCA or patient request Surgery 90-32% 80-26% Hours 6-28 (P < 0.001) Surgery Hours 6-28 (P<.001) At Rest With Movement Placebo Placebo 800 mg IV IBU 800 mg IV IBU VAS = visual analog scale * Statistical significance at each assessment point. Singla, et al A multi-center, randomized, double-blind placebo-controlled trial of intravenous-ibuprofen (IV-ibuprofen) for treatment of pain in post-operative orthopedic adult patients. Pain Med. Aug 2010;11(8): IV ibuprofen contraindications Respiratory: Patients experiencing asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs Cardiovascular risk NSAIDs may increase risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. Risk may increase with duration of use. IV IBU is contraindicated for the treatment of perioperative pain in the setting of CABG surgery. Gastrointestinal risk NSAIDs increase risk of serious GI adverse events, including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. Events can occur at any time without warning symptoms. Elderly patients are at greater risk. 8

7 Cox-3 Ø COX-3 and two smaller COX-1 proteins identified (PCOX-1) Ø Selectively inhibited by acetaminophen. Ø May explain why acetaminophen is antipyretic and analgesic without affecting COX-1 or COX-2. Ø Potently inhibited by diclofenac, aspirin, and ibuprofen. Ø New drug development that selectively inhibits COX-3. Senior K. Homing in on Cox-3 the elusive target of paracetamol. Lancet 2002 vol Schwab JM, Schluesener HJ, Laufer S. Lancet 2003; 361: ASA, Ibuprofen and acetaminophen Ø 1/3-1/2 less GI adverse effect than aspirin Ø Lowest risk of NSAIDs for UGI bleed or perforation Ø Blinded RCT comparing adverse events for l l l ASA tabs (up to 3 g/day) Acetaminophen (up to 3 g/d) and Ibuprofen (up to 1.2 g/day) Ø Adverse events: l Ibuprofen 13.7%, acetaminophen 14.5% aspirin 18.7%. l No stat difference between ibuprofen and acetaminophen l GI events: ibuprofen (4%) acetaminophen (5.3%) aspirin (7.1%) l 6 GI bleeds: 4 with acetaminophen and 2 with aspirin. Moore N, van Ganse E, Le Parc J-M et al (1999). The PAIN study: paracetamol, aspirin and ibuprofen new tolerability study. A large-scale, randomized clinical trial comparing the tolerability of aspirin, ibuprofen and paracetamol for shortterm analgesia. Clin Drug Invest 18:89-98

8 Peri-operative acetaminophen (ACET) Theory is that of ACET's positive effects on the serotonergic descending inhibitory pathways. However, interactions with opioidergic systems, eicosanoid systems, and/or nitric oxide containing pathways may be involved as well. Furthermore, endocannabinoid signaling may play a role in ACET's activation of the serotonergic descending inhibitory pathways. 1 Theorized that ACET has no affinity for the active site of cyclo-oxygenase but instead blocks central activity by reducing the active oxidized form of cyclo-oxygenase to an inactive form. 2 Combination ACET/IBU better analgesia than Tylenol No. 3 (p = 0.018). More side effects and higher discontinuation with Tylenol No. 3 (p = 0.045). 3 Need CNS levels for effect: Analgesia better when ACET given early at induction compared to end of case. 4 Even IV ACET 30 min preoperatively not better than oral post op IBU Smith HS. Potential analgesic mechanisms of acetaminophen. Pain Physician 2009 Jan-Feb;12(1): Lucas R, Warner TD, Vojnovic I, Mitchell JA. Cellular mechanisms of acetaminophen: role of cyclo-oxygenase. Faseb J 2005 Apr;19(6): Mitchell A, van Zanten SV, Inglis K, Porter G. A randomized controlled trial comparing acetaminophen plus ibuprofen versus acetaminophen plus codeine plus caffeine after outpatient general surgery. Journal of the American College of Surgeons 2008 Mar;206(3): Arici S, Gurbet A, Turker G, Yavascaoglu B, Sahin S. Preemptive analgesic effects of intravenous paracetamol in total abdominal hysterectomy. Agri 2009 Apr;21(2): Alhashemi JA, Alotaibi QA, Mashaat MS, Kaid TM, Mujallid RH, Kaki AM. Intravenous acetaminophen vs oral ibuprofen in combination with morphine PCIA after Cesarean delivery. Can J Anaesth 2006 Dec;53(12): Plasma CSF levels Gastric absorption of oral ACET is unreliable perioperatively in the starved and stressed patient. Parenteral ACET gave therapeutic concentrations in 96% given parenteral, and 67% given oral ACET. Parenteral ACET gave higher plasma concentrations throughout the study period. Parenteral ACET gave more reliable therapeutic plasma concentrations than oral. van der Westhuizen, et al. (2011). "Randomised controlled trial comparing oral and intravenous paracetamol (acetaminophen) plasma levels when given as preoperative analgesia." Anaesthesia and intensive care 39(2):

9 Randomized controlled trial IV acetaminophen 2g Pain reduction Narcotic reduction Hysterectomy % Highly selective COX-2,3 inhibitor blocks uptake of endogenous cannabinoid/vanilloid anandamide by pain neurons. CNS analgesia. Lower incidence of postop N&V with IV acetaminophen. IV provides better serum levels than PO Moon YE, et al The effects of preoperative intravenous acetaminophen in patients undergoing abdominal hysterectomy. Archives of gynecology and obstetrics ! van der Westhuizen J, et al Randomised controlled trial comparing oral and intravenous paracetamol (acetaminophen) plasma levels when given as preoperative analgesia. Anaesth Intensive Care A Multimodal Approach Addresses the Complex Nature of Pain Transmission Opioids, Alpha-2 agonists 1 Acetaminophen, some NSAIDs NE-reuptake inhibitors 2 Ascending input via Spinothalamic tract Descending modulation Local anesthetics (epidural), Opioids, Alpha-2 agonists 1 Dorsal horn Local anesthetics (peripheral nerve block) 1 Local anesthetics (field block), NSAIDs, Coxibs 1 NE = norepinephrine NSAIDs = nonsteroidal anti-inflammatory drugs Peripheral nerve 1. Adapted from Gottschalk A & Smith D. Am Fam Physician. 2001;63: Iyengar S et al. J Pharmacol Exp Ther. 2004;311: Pain Peripheral nociceptors 12

10 Multimodal perioperative analgesia Ø Must be parenteral for effective pre-incision serum and CSF levels. Ø IV Ibuprofen safe and effective, more expensive. Ø IV Ketorolac highest risk of GI bleed, cheapest. Must halve dose for age>65. Ø IV Acetaminophen: no GI risk. Not for hepatic impairment. Complements either IBU or KET. Kate s picks Pre-op: IV IBU 800mg + IV acetaminophhen 1,000mg for all. IV Protonix 40 for those with GERD, PUD. Redose in PACU if transfused >3 uprbc. Post-op: Age>65: IV IBU 800 q6h until PO Naproxen 500 q6h Age<65: IV KET 30 q6h until PO Naproxen 500 q6h IV acetaminophhen 1,000mg for all, until PO Acetaminophen 650 q6h. Discharge: continue NSAID/acetaminophen 650 q6h x3days

Balanced Analgesia With NSAIDS and Coxibs. Raymond S. Sinatra MD, Ph.D

Balanced Analgesia With NSAIDS and Coxibs. Raymond S. Sinatra MD, Ph.D Balanced Analgesia With NSAIDS and Coxibs Raymond S. Sinatra MD, Ph.D Prostaglandins and Pain The primary noxious mediator released from damaged tissue is prostaglandin (PG) PG is responsible for nociceptor

More information

NSAIDs: Side Effects and Guidelines

NSAIDs: Side Effects and Guidelines NSAIDs: Side Effects and James J Hale FY1 Department of Anaesthetics Introduction The non-steroidal anti-inflammatory drugs (NSAIDs) are a diverse group of drugs that have analgesic, antipyretic and anti-inflammatory

More information

Iroko Pharmaceuticals Announces Acceptance for Filing of ZORVOLEX snda for the Treatment of Osteoarthritis Pain in Adults

Iroko Pharmaceuticals Announces Acceptance for Filing of ZORVOLEX snda for the Treatment of Osteoarthritis Pain in Adults Iroko Pharmaceuticals Announces Acceptance for Filing of ZORVOLEX snda for the Treatment of Osteoarthritis Pain in Adults First Lower Dose NSAID Using SoluMatrix Fine Particle Technology to be Reviewed

More information

Effective pain management begins with OFIRMEV (acetaminophen) injection FIRST Proven efficacy with rapid reduction in pain 1

Effective pain management begins with OFIRMEV (acetaminophen) injection FIRST Proven efficacy with rapid reduction in pain 1 Effective pain management begins with OFIRMEV (acetaminophen) injection FIRST Proven efficacy with rapid reduction in pain 1 Fast onset of pain relief with 7% reduction in visual analog scale (VAS) scores

More information

OFIRMEV a non-opioid, non-nsaid, intravenous analgesic for the management of pain

OFIRMEV a non-opioid, non-nsaid, intravenous analgesic for the management of pain FOR PHARMACY PROFESSIONALS In pharmacokinetic studies Rapid time to reach Cmax with IV acetaminophen OFIRMEV from the start OFIRMEV g demonstrated early and high Cmax at minutes Consider administering

More information

Pain: A Public Health Challenge. NSAIDS for Managing Pain. Iroko: Innovators in Analgesia

Pain: A Public Health Challenge. NSAIDS for Managing Pain. Iroko: Innovators in Analgesia Pain: A Public Health Challenge Despite advances in understanding and treatment, pain remains a major public health challenge 1 that exacts a significant personal and economic toll on Americans 2. Pain

More information

This document has not been circulated to either the industry or Consultants within the Suffolk system.

This document has not been circulated to either the industry or Consultants within the Suffolk system. New Medicine Report Document Status COX II Inhibitors In Acute Analgesia For Suffolk Drug & Therapeutics Committee Date of Last Revision 15 th February 2002 Reviewer s Comments There seems to be a growing

More information

disease or in clients who consume alcohol on a regular basis. bilirubin

disease or in clients who consume alcohol on a regular basis. bilirubin NON-OPIOID Acetaminophen(Tylenol) Therapeutic class: Analgesic, antipyretic Aspirin (ASA, Acetylsalicylic Acid) Analgesic, NSAID, antipyretic Non-Opioid Analgesics COMMON USES WHAT I NEED TO KNOW AS A

More information

A. Correct! Nociceptors are pain receptors stimulated by harmful stimuli, resulting in the sensation of pain.

A. Correct! Nociceptors are pain receptors stimulated by harmful stimuli, resulting in the sensation of pain. Pharmacology - Problem Drill 19: Anti-Inflammatory and Analgesic Drugs No. 1 of 10 1. are pain receptors stimulated by harmful stimuli, resulting in the sensation of pain. #01 (A) Nociceptors (B) Histamines

More information

Gastrointestinal Safety of Coxibs and Outcomes Studies: What s the Verdict?

Gastrointestinal Safety of Coxibs and Outcomes Studies: What s the Verdict? Vol. 23 No. 4S April 2002 Journal of Pain and Symptom Management S5 Proceedings from the Symposium The Evolution of Anti-Inflammatory Treatments in Arthritis: Current and Future Perspectives Gastrointestinal

More information

R Sim, D Cheong, KS Wong, B Lee, QY Liew Tan Tock Seng Hospital Singapore

R Sim, D Cheong, KS Wong, B Lee, QY Liew Tan Tock Seng Hospital Singapore Prospective randomized, double-blind, placebo-controlled study of pre- and postoperative administration of a COX-2- specific inhibitor as opioid-sparing analgesia in major colorectal resections R Sim,

More information

Iroko Pharmaceuticals Receives FDA Approval for VIVLODEX - First Low Dose SoluMatrix Meloxicam for Osteoarthritis Pain

Iroko Pharmaceuticals Receives FDA Approval for VIVLODEX - First Low Dose SoluMatrix Meloxicam for Osteoarthritis Pain Iroko Pharmaceuticals Receives FDA Approval for VIVLODEX - First Low Dose SoluMatrix Meloxicam for Osteoarthritis Pain VIVLODEX Developed to Align with FDA NSAID Recommendations Proven Efficacy at Low

More information

CARDIOVASCULAR RISK and NSAIDs

CARDIOVASCULAR RISK and NSAIDs CARDIOVASCULAR RISK and NSAIDs Dr. Syed Ghulam Mogni Mowla Assistant Professor of Medicine Shaheed Suhrawardy Medical College, Dhaka INTRODUCTION NSAIDs are most commonly prescribed drugs Recent evidence

More information

Pain: A Public Health Challenge. NSAIDS for Managing Pain. Iroko: Innovators in Analgesia

Pain: A Public Health Challenge. NSAIDS for Managing Pain. Iroko: Innovators in Analgesia Pain: A Public Health Challenge Despite advances in understanding and treatment, pain remains a major public health challenge 1 that exacts a significant personal and economic toll on Americans. 1 Pain

More information

Vimovo (delayed-release enteric-coated naproxen with esomeprazole)

Vimovo (delayed-release enteric-coated naproxen with esomeprazole) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.17.01 Subject: Vimovo Page: 1 of 5 Last Review Date: September 18, 2015 Vimovo Description Vimovo (delayed-release

More information

A Randomized Trial Comparing the Safety and Efficacy of Intravenous Ibuprofen versus Ibuprofen and Acetaminophen in Knee or Hip Arthroplasty

A Randomized Trial Comparing the Safety and Efficacy of Intravenous Ibuprofen versus Ibuprofen and Acetaminophen in Knee or Hip Arthroplasty Pain Physician 2016; 19:349-356 ISSN 1533-3159 Randomized Trial A Randomized Trial Comparing the Safety and Efficacy of Intravenous Ibuprofen versus Ibuprofen and Acetaminophen in Knee or Hip Arthroplasty

More information

Month/Year of Review: January 2012 Date of Last Review: February 2007

Month/Year of Review: January 2012 Date of Last Review: February 2007 Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-945-5220 Fax 503-947-1119 Month/Year of Review: January 2012 Date of Last Review:

More information

TIVORBEX Now Available in U.S. Pharmacies for the Treatment of Acute Pain

TIVORBEX Now Available in U.S. Pharmacies for the Treatment of Acute Pain TIVORBEX Now Available in U.S. Pharmacies for the Treatment of Acute Pain Second Low-Dose SoluMatrix NSAID from Iroko Now Available by Prescription PHILADELPHIA, June 29, 2015 Iroko Pharmaceuticals, LLC,

More information

TACKLING THE OPIOID EPIDEMIC: THE DENTAL TEAM'S RESPONSIBILITY ACUTE PAIN MANAGEMENT

TACKLING THE OPIOID EPIDEMIC: THE DENTAL TEAM'S RESPONSIBILITY ACUTE PAIN MANAGEMENT TACKLING THE OPIOID EPIDEMIC: THE DENTAL TEAM'S RESPONSIBILITY ACUTE PAIN MANAGEMENT John E. Lindroth, DDS Associate Professor University of Kentucky College of Dentistry FACULTY DISCLOSURE Neither my

More information

Intravenous ibuprofen for postoperative pain

Intravenous ibuprofen for postoperative pain Review For reprint orders, please contact: reprints@futuremedicine.com Intravenous ibuprofen for postoperative pain Peter B Kroll* Practice Points Intravenous (iv.) ibuprofen is a key addition to the perioperative

More information

NSAID Use in Post- Myocardial Infarction Patients. Leah Jackson, BScPhm Pharmacy Resident Cardiology Rotation February 28, 2007

NSAID Use in Post- Myocardial Infarction Patients. Leah Jackson, BScPhm Pharmacy Resident Cardiology Rotation February 28, 2007 NSAID Use in Post- Myocardial Infarction Patients Leah Jackson, BScPhm Pharmacy Resident Cardiology Rotation February 28, 2007 Objectives By the end of the presentation, the audience will be able to use

More information

NSAID Use in Post- Myocardial Infarction Patients

NSAID Use in Post- Myocardial Infarction Patients NSAID Use in Post- Myocardial Infarction Patients Leah Jackson, BScPhm Pharmacy Resident Cardiology Rotation February 28, 2007 Objectives By the end of the presentation, the audience will be able to use

More information

Gastrointestinal Safety of Aspirin for a High-Dose, Multiple-Day Treatment Regimen: A Meta-Analysis of Three Randomized Controlled Trials

Gastrointestinal Safety of Aspirin for a High-Dose, Multiple-Day Treatment Regimen: A Meta-Analysis of Three Randomized Controlled Trials Drugs R D (2016) 16:263 269 DOI 10.1007/s40268-016-0138-8 ORIGINAL RESEARCH ARTICLE Gastrointestinal Safety of Aspirin for a High-Dose, Multiple-Day Treatment Regimen: A Meta-Analysis of Three Randomized

More information

Drug Use Criteria: Oral Ketorolac/Intranasal Ketorolac (Sprix )

Drug Use Criteria: Oral Ketorolac/Intranasal Ketorolac (Sprix ) Texas Vendor Program Use Criteria: Oral Ketorolac/Intranasal Ketorolac (Sprix ) Publication History 1. Developed February 1995. 2. Revised May 2016; December 2014; March 2013; May 2011; January 2009; October

More information

BJF Acute Pain Team Formulary Group

BJF Acute Pain Team Formulary Group Title Analgesia Guidelines for Acute Pain Management (Adults) in BGH Document Type Issue no Clinical guideline Clinical Governance Support Team Use Issue date April 2013 Review date April 2015 Distribution

More information

AVERTING RISKS ASSOCIATED WITH UTILISING SMALL ANIMAL NSAIDS

AVERTING RISKS ASSOCIATED WITH UTILISING SMALL ANIMAL NSAIDS Vet Times The website for the veterinary profession https://www.vettimes.co.uk AVERTING RISKS ASSOCIATED WITH UTILISING SMALL ANIMAL NSAIDS Author : Catherine F Le Bars Categories : Vets Date : April 6,

More information

PAIN & ANALGESIA. often accompanied by clinical depression. fibromyalgia, chronic fatigue, etc. COX 1, COX 2, and COX 3 (a variant of COX 1)

PAIN & ANALGESIA. often accompanied by clinical depression. fibromyalgia, chronic fatigue, etc. COX 1, COX 2, and COX 3 (a variant of COX 1) Pain - subjective experience associated with detection of tissue damage ( nociception ) acute - serves as a warning chronic - nociception gone bad often accompanied by clinical depression fibromyalgia,

More information

Digital RIC. Rhode Island College. Linda M. Green Rhode Island College

Digital RIC. Rhode Island College. Linda M. Green Rhode Island College Rhode Island College Digital Commons @ RIC Master's Theses, Dissertations, Graduate Research and Major Papers Overview Master's Theses, Dissertations, Graduate Research and Major Papers 1-1-2013 The Relationship

More information

Improved acute pain management starts here 1

Improved acute pain management starts here 1 Improved acute pain management starts here 1 Indication OFIRMEV is indicated for the management of mild to moderate pain; the management of moderate to severe pain with adjunctive opioid analgesics; and

More information

PAIN PODCAST SHOW NOTES:

PAIN PODCAST SHOW NOTES: PAIN PODCAST SHOW NOTES: Dallas Holladay, DO Ultrasound Fellow Cook County Hospital Rush University Medical Center Jonathan D. Alterie, DO PGY-2, Emergency Medicine Midwestern University An overview of

More information

Cymbalta anti inflammatory

Cymbalta anti inflammatory Cymbalta anti inflammatory The Borg System is 100 % Cymbalta anti inflammatory 11/01/2017 Abcya math man games 11/02/2017 Lalaloopsy 11/03/2017 Free keno wheels Cymbalta and ibuprofen. View detailed information

More information

Disclosure. Learning Objectives 1/17/2018. Pumping the Breaks in Pain Management: An Update on Cardiovascular Risk with NSAID Use

Disclosure. Learning Objectives 1/17/2018. Pumping the Breaks in Pain Management: An Update on Cardiovascular Risk with NSAID Use Disclosure Pumping the Breaks in Pain Management: An Update on Cardiovascular Risk with Liz Van Dril, PharmD, BCPS PGY2 Ambulatory Care Resident January 17 th, 2018 Dr. Liz Van Dril has no actual or potential

More information

ASPIRIN AND VASCULAR DISEASE

ASPIRIN AND VASCULAR DISEASE ASPIRIN AND VASCULAR DISEASE SUMMARY Aspirin is an effective antiplatelet agent for patients with cardiovascular and cerebrovascular disease. Incidence of adverse effects and drug interactions increases

More information

Iroko Pharmaceuticals Gains Additional Patents for ZORVOLEX and TIVORBEX TM

Iroko Pharmaceuticals Gains Additional Patents for ZORVOLEX and TIVORBEX TM Iroko Pharmaceuticals Gains Additional Patents for ZORVOLEX and TIVORBEX TM PHILADELPHIA, April 8, 2015 Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the

More information

NONSTEROIDAL ANTI- INFLAMMATORY DRUGS

NONSTEROIDAL ANTI- INFLAMMATORY DRUGS NONSTEROIDAL ANTI- INFLAMMATORY DRUGS MRS. M.M. HAS A 3 YR. HX OF PROGRESSIVE RIGHT HIP PAIN. THE PAIN INCREASES WITH WEIGHT BEARING ACTIVITY. PT. HAS BEEN ON ACETAMINOPHEN WITHOUT RELIEF. PERTINENT LABS

More information

Ibuprofen. Ibuprofen and Paracetamol: prescribing overview. Ibuprofen indications CYCLO-OXYGENASE (COX I) CYCLO-OXEGENASE (COX II) INFLAMMATORY PAIN

Ibuprofen. Ibuprofen and Paracetamol: prescribing overview. Ibuprofen indications CYCLO-OXYGENASE (COX I) CYCLO-OXEGENASE (COX II) INFLAMMATORY PAIN Ibuprofen Ibuprofen and Paracetamol: prescribing overview Sarah Holloway Macmillan CNS in palliative care NSAID Non-selective COX inhibitor Oral bioavailability: 90% Onset of action: 20-30 mins (can take

More information

NSAIDs Overview. Souraya Domiati, Pharm D, MS

NSAIDs Overview. Souraya Domiati, Pharm D, MS NSAIDs Overview Souraya Domiati, Pharm D, MS Case A 32 years old shows up into your pharmacy asking for an NSAID for his ankle pain He smokes1 pack/day His BP is 125/75mmHg His BMI is 35kg/m2 His is on

More information

Ask your healthcare provider if SPRIX (ketorolac tromethamine) Nasal Spray is right for you

Ask your healthcare provider if SPRIX (ketorolac tromethamine) Nasal Spray is right for you For pain that requires opioid-strength relief... You have a non-opioid option RIGHT UNDER YOUR NOSE Ask your healthcare provider if SPRIX (ketorolac tromethamine) Nasal Spray is right for you What is SPRIX?

More information

Associate Professor Supranee Niruthisard Department of Anesthesiology Faculty of Medicine Chulalongkorn University January 21, 2008

Associate Professor Supranee Niruthisard Department of Anesthesiology Faculty of Medicine Chulalongkorn University January 21, 2008 Associate Professor Supranee Niruthisard Department of Anesthesiology Faculty of Medicine Chulalongkorn University January 21, 2008 PAIN MECHANISMS Somatic Nociceptive Visceral Inflammatory response sensitizes

More information

Analgesics. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine The University of Jordan March, 2014

Analgesics. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine The University of Jordan March, 2014 Analgesics Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine The University of Jordan March, 2014 Mar-14 Munir Gharaibeh, MD, PhD, MHPE 2 Feature Comparison of Analgesics Narcotic (Opioids) Nonnarcotic

More information

Learning Objectives. Perioperative goals. Acute Pain in the Chronic Pain Patient for Ambulatory Surgery 9/8/16

Learning Objectives. Perioperative goals. Acute Pain in the Chronic Pain Patient for Ambulatory Surgery 9/8/16 Acute Pain in the Chronic Pain Patient for Ambulatory Surgery Danielle Ludwin, MD Associate Professor of Anesthesiology Division of Regional and Orthopedic Anesthesia Columbia University Medical Center

More information

EXPAREL. An Innovative Non-Opioid Option for the Management of Postsurgical Pain. Presenter s Name Affiliation Date

EXPAREL. An Innovative Non-Opioid Option for the Management of Postsurgical Pain. Presenter s Name Affiliation Date EXPAREL An Innovative Non-Opioid Option for the Management of Postsurgical Pain Presenter s Name Affiliation Date Disclosures The speaker has a consulting relationship with Pacira Pharmaceuticals, Inc.

More information

Review Article. Safety Profile of Nonsteroidal Antiflammatory Drugs (NSAID) Safety Profile of NSAID

Review Article. Safety Profile of Nonsteroidal Antiflammatory Drugs (NSAID) Safety Profile of NSAID Safety Profile of Nonsteroidal Antiflammatory Drugs (NSAID) R. Stoilov: University Hospital St Ivan Rilski, Clinic of Rheumatology Contact: Rumen Stoilov, Clinic of Rheumatology, University Hospital St

More information

Pain therapeutics. Acetaminophen/NSAIDs Acute pain Osteoarthritis Migraine Acute Gout Neuropathic pain

Pain therapeutics. Acetaminophen/NSAIDs Acute pain Osteoarthritis Migraine Acute Gout Neuropathic pain Pain therapeutics Acetaminophen/NSAIDs Acute pain Osteoarthritis Migraine Acute Gout Neuropathic pain James McCormack, Pharm.D. Professor Faculty of Pharmaceutical Sciences, UBC Common types of pain killers

More information

PAIN MANAGEMENT IN HIP SURGERY. Khoa D. Nguyen, MD, PhD Dept. of Rheumatology, Cho Ray Hosital

PAIN MANAGEMENT IN HIP SURGERY. Khoa D. Nguyen, MD, PhD Dept. of Rheumatology, Cho Ray Hosital PAIN MANAGEMENT IN HIP SURGERY Khoa D. Nguyen, MD, PhD Dept. of Rheumatology, Cho Ray Hosital MUSCULOSKELETAL PAIN IS COMMON Hip replacement increasing POSTOPERATIVE PAIN: INTRODUCTION Very common Causes

More information

Acute Peri-Operative Pain Management Strategies

Acute Peri-Operative Pain Management Strategies Slide 1 Acute Peri-Operative Pain Management Strategies Phillip Gallegos, MD USAP Pinnacle Anesthesiologist Director of Anesthesia and Peri-Operative Medicine BOSHA Slide 2 ERAS Enhanced Recovery After

More information

Celecoxib: the need to know for safe prescribing

Celecoxib: the need to know for safe prescribing medicine indications pain management rheumatology Celecoxib: the need to know for safe prescribing Celecoxib is a selective cyclo-oxygenase-2 (COX-2) inhibitor that has been fully subsidised without restriction,

More information

Medicines Q&As. Medicines Q&As. What is the evidence to support the use of IV paracetamol for the treatment of pain? Background.

Medicines Q&As. Medicines Q&As. What is the evidence to support the use of IV paracetamol for the treatment of pain? Background. Medicines Q&As Q&A 361.1 What is the evidence to support the use of IV paracetamol for the treatment of pain? Background Prepared by UK Medicines Information (UKMi) pharmacists for NHS healthcare professionals

More information

... REPORTS... The Use and Effect of Analgesics in Patients Who Regularly Drink Alcohol. Richard C. Dart, MD, PhD

... REPORTS... The Use and Effect of Analgesics in Patients Who Regularly Drink Alcohol. Richard C. Dart, MD, PhD ... REPORTS... The Use and Effect of Analgesics in Patients Who Regularly Drink Alcohol Richard C. Dart, MD, PhD Abstract Analgesic consumption poses special risks for regular users of alcohol. Among the

More information

Drug Class Review on Cyclo-oxygenase (COX)-2 Inhibitors and Non-steroidal Anti-inflammatory Drugs (NSAIDs)

Drug Class Review on Cyclo-oxygenase (COX)-2 Inhibitors and Non-steroidal Anti-inflammatory Drugs (NSAIDs) Drug Class Review on Cyclo-oxygenase (COX)-2 Inhibitors and Non-steroidal Anti-inflammatory Drugs (NSAIDs) Final Report Update 3 Evidence Tables November 2006 Original Report Date: May 2002 Update 1 Report

More information

Celecoxib Powder, Diclofenac Powder, Flurbiprofen Powder, Ibuprofen Powder, Ketoprofen Powder, Meloxicam Powder, Tramadol Powder

Celecoxib Powder, Diclofenac Powder, Flurbiprofen Powder, Ibuprofen Powder, Ketoprofen Powder, Meloxicam Powder, Tramadol Powder Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.02.26 Subject: Anti-Inflammatory Pain Powders Page: 1 of 5 Last Review Date: December 3, 2015 Anti-Inflammatory

More information

PERIOPERATIVE PAIN MANAGEMENT: WHAT S UP WITH METHADONE?

PERIOPERATIVE PAIN MANAGEMENT: WHAT S UP WITH METHADONE? PERIOPERATIVE PAIN MANAGEMENT: WHAT S UP WITH METHADONE? Sandra Z Perkowski, VMD, PhD, DACVAA University of Pennsylvania, School of Veterinary Medicine, Philadelphia, PA Pre-emptive and multimodal use

More information

Elements for a Public Summary Overview of disease epidemiology

Elements for a Public Summary Overview of disease epidemiology VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Acute pain usually responds to medication and should settle in less than three months. Inadequate pain relief may lead to other

More information

Show Me the Evidence: Epidurals, PVBs, TAP Blocks Christopher L. Wu, MD Professor of Anesthesiology The Johns Hopkins Hospital

Show Me the Evidence: Epidurals, PVBs, TAP Blocks Christopher L. Wu, MD Professor of Anesthesiology The Johns Hopkins Hospital Show Me the Evidence: Epidurals, PVBs, TAP Blocks Christopher L. Wu, MD Professor of Anesthesiology The Johns Hopkins Hospital Overview Review overall (ERAS and non-eras) data for EA, PVB, TAP Examine

More information

What s New in Post-Cesarean Analgesia?

What s New in Post-Cesarean Analgesia? Anesthesia & Obstetrics What s New in Post-Cesarean Analgesia? October 23rd, 2013 2013 UCSF What Does The Evidence Tell Us? Mark Rollins, MD, PhD UC SF Post-Delivery Pain (Mean pain scores for first 24

More information

5 MUSCULOSKELETAL SYSTEM

5 MUSCULOSKELETAL SYSTEM 5 MUSCULOSKELETAL SYSTEM 5.01 NON-STEROIDAL ANTIILAMMATORY DRUGS (NSAIDS) *Acetylsalicylic Acid (Aspirin) Tab Soluble 300mg Diclofenac Sodium Tab 25mg, Supp 25mg, 50mg & 100mg (Voltaren) 300-900mg every

More information

ENHANCED RECOVERY PROTOCOLS FOR KNEE REPLACEMENT

ENHANCED RECOVERY PROTOCOLS FOR KNEE REPLACEMENT ENHANCED RECOVERY PROTOCOLS FOR KNEE REPLACEMENT Jeff Gadsden, MD, FRCPC, FANZCA Associate Professor Duke University Department of Anesthesiology Regional Anesthesia and Acute Pain Medicine DISCLOSURES

More information

Fast Track Surgery and Surgical Carepath in Optimising Colorectal Surgery. R Sim Centre for Advanced Laparoscopic Surgery, TTSH

Fast Track Surgery and Surgical Carepath in Optimising Colorectal Surgery. R Sim Centre for Advanced Laparoscopic Surgery, TTSH Fast Track Surgery and Surgical Carepath in Optimising Colorectal Surgery R Sim Centre for Advanced Laparoscopic Surgery, TTSH Conventional Surgery Postop care Nasogastric tube Enteral feeds when ileus

More information

! Somatic! Visceral! Neuropathic! Psychogenic. ! Analgesic! Relief without sedation! Works on peripheral pain receptors

! Somatic! Visceral! Neuropathic! Psychogenic. ! Analgesic! Relief without sedation! Works on peripheral pain receptors PAIN, PAIN, GO AWAY. TYPES OF PAIN! Somatic! Visceral! Neuropathic! Psychogenic Jill Autry, OD, RPh Eye Center of Texas, Houston drjillautry@tropicalce.com ANALGESIA! Mild! Aspirin! Paracetamol! Moderate!

More information

FOR PAIN RELIEF CHOOSE AT THE OPIOID LEVEL DIRECT SAVINGS, DIRECT TO YOUR PATIENTS. Support for Your Practice. Support for Patients

FOR PAIN RELIEF CHOOSE AT THE OPIOID LEVEL DIRECT SAVINGS, DIRECT TO YOUR PATIENTS. Support for Your Practice. Support for Patients DIRECT SAVINGS, DIRECT TO YOUR PATIENTS SPRIX Direct provides your patients with their medication EXCLUSIVELY through Cardinal Health Specialty Pharmacy Indications and Usage FOR PAIN RELIEF AT THE OPIOID

More information

Peri operative pain control. Disclosure. Objectives 9/1/2011. No current conflicts of interest

Peri operative pain control. Disclosure. Objectives 9/1/2011. No current conflicts of interest Peri operative pain control Chris Herndon, PharmD, FASHP Southern Illinois University Edwardsville Disclosure No current conflicts of interest Objectives Discuss studies evaluating the transformation of

More information

A comparison of Ketoprofen and Diclofenac for acute musculoskeletal pain relief: a prospective randomised clinical trial

A comparison of Ketoprofen and Diclofenac for acute musculoskeletal pain relief: a prospective randomised clinical trial Hong Kong Journal of Emergency Medicine A comparison of Ketoprofen and Diclofenac for acute musculoskeletal pain relief: a prospective randomised clinical trial P Ng, CW Kam, HH Yau Objectives: To compare

More information

Intravenous Ibuprofen

Intravenous Ibuprofen ADIS DRUG PROFILE Drugs 2012; 72 (8): 1099-1109 0012-6667/12/0008-1099/$55.55/0 Adis ª 2012 Springer International Publishing AG. All rights reserved. Intravenous Ibuprofen In Adults For Pain and Fever

More information

Gastrointestinal Tolerability of Ibuprofen Compared with Paracetamol and Aspirin at Over-the-counter Doses

Gastrointestinal Tolerability of Ibuprofen Compared with Paracetamol and Aspirin at Over-the-counter Doses The Journal of International Medical Research 2002; 30: 301 308 Gastrointestinal Tolerability of Ibuprofen Compared with Paracetamol and Aspirin at Over-the-counter Doses P RAMPAL 1, N MOORE 2, E VAN GANSE

More information

PRESCRIBING SUPPORT TEAM AUDIT: Etoricoxib hypertension safety evaluation

PRESCRIBING SUPPORT TEAM AUDIT: Etoricoxib hypertension safety evaluation PRESCRIBING SUPPORT TEAM AUDIT: Etoricoxib hypertension safety evaluation DATE OF AUTHORISATION: AUTHORISING GP: PRESCRIBING SUPPORT TECHNICIAN: SUMMARY This audit has been designed to ensure that patients

More information

A Literature Review of Randomized Clinical Trials of Intravenous Acetaminophen (Paracetamol) for Acute Postoperative Pain

A Literature Review of Randomized Clinical Trials of Intravenous Acetaminophen (Paracetamol) for Acute Postoperative Pain papr_426 290..296 REVIEW ARTICLE A Literature Review of Randomized Clinical Trials of Intravenous Acetaminophen (Paracetamol) for Acute Postoperative Pain Alex Macario, MD, MBA*; Mike A. Royal, MD, JD,

More information

Continuous Wound Infusion and Postoperative Pain Current status?

Continuous Wound Infusion and Postoperative Pain Current status? Continuous Wound Infusion and Postoperative Pain Current status? Pr Patricia Lavand homme Department of Anesthesiology St Luc Hospital University Catholic of Louvain Medical School Brussels, Belgium Severe

More information

NSAID Regional Audit Group Presentation. Audit Group: Dr Richard Latten, Ruth Clark, Dr Sarah Fradsham, Dr Seamus Coyle, Claire Johnston

NSAID Regional Audit Group Presentation. Audit Group: Dr Richard Latten, Ruth Clark, Dr Sarah Fradsham, Dr Seamus Coyle, Claire Johnston NSAID Regional Audit Group Presentation Audit Group: Dr Richard Latten, Ruth Clark, Dr Sarah Fradsham, Dr Seamus Coyle, Claire Johnston Thank you from the audit group for all who participated in the data

More information

Research and Reviews: Journal of Medical and Health Sciences

Research and Reviews: Journal of Medical and Health Sciences Research and Reviews: Journal of Medical and Health Sciences Comparison of Paracetamol infusion with Diclofenac infusion for perioperative analgesia. Yoganarasimha N*, Raghavendra TR, Radha MK, Amitha

More information

Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs?

Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs? et al. DOI:10.1111/j.1365-2125.2003.02012.x British Journal of Clinical Pharmacology Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs? Mary Teeling, Kathleen Bennett

More information

The Use of Analgesics in Rodents and Rabbits Deborah M. Mook, DVM

The Use of Analgesics in Rodents and Rabbits Deborah M. Mook, DVM The Use of Analgesics in Rodents and Rabbits Deborah M. Mook, DVM (Last updated August, 2005) Rationale. Well-established studies have shown repeatedly that effective analgesia enhances locomotion, increases

More information

Acute Pain Management in the Opioid Tolerant Patient. Objectives. Opioids. The participant will be able to define opioid tolerance

Acute Pain Management in the Opioid Tolerant Patient. Objectives. Opioids. The participant will be able to define opioid tolerance Acute Pain Management in the Opioid Tolerant Patient Kathleen M. Colfer, MSN, RN-BC Clinical Nurse Specialist Acute Pain Management Service Department of Anesthesiology Thomas Jefferson University Hospital

More information

Anaesthesia and Pain Management for Endo Exo Femoral Prosthesis (EEFP) Bridging the Gap from Surgery to Rehabilitation

Anaesthesia and Pain Management for Endo Exo Femoral Prosthesis (EEFP) Bridging the Gap from Surgery to Rehabilitation Anaesthesia and Pain Management for Endo Exo Femoral Prosthesis (EEFP) Bridging the Gap from Surgery to Rehabilitation Dr Ajay Kumar Senior Lecturer Macquarie and Melbourne University Introduction Amputee

More information

Etoricoxib STADA 30 mg, 60 mg, 90 mg and 120 mg film-coated tablets , Version V1.2 PUBLIC SUMMARY OF THE RISK MANAGEMENT PLAN

Etoricoxib STADA 30 mg, 60 mg, 90 mg and 120 mg film-coated tablets , Version V1.2 PUBLIC SUMMARY OF THE RISK MANAGEMENT PLAN Etoricoxib STADA 30 mg, 60 mg, 90 mg and 120 mg film-coated tablets 23.5.2016, Version V1.2 PUBLIC SUMMARY OF THE RISK MANAGEMENT PLAN VI.2 Elements for a Public Summary Etoricoxib STADA 30 mg film-coated

More information

Inpatient Management of Trauma Related Pain

Inpatient Management of Trauma Related Pain Inpatient Management of Trauma Related Pain STOMP Summit September 9, 2016 Ann O Rourke, MD, MPH University of Wisconsin Department of Surgery 1 Our patient Small SDH Intubated Hemopneumothorax with multiple

More information

AN NSAID WITH A BALANCED COX-1 & COX-2 INHIBITORY EFFECT

AN NSAID WITH A BALANCED COX-1 & COX-2 INHIBITORY EFFECT AN NSAID WITH A BALANCED COX-1 & COX-2 INHIBITORY EFFECT A balanced cox-1 and cox-2 inhibitor Metabolisim and Bioavailabillty of Lornoxicam (3) Relative selectivity of agents as inhibitors of cox-1 and

More information

COX-2 inhibitors: A cautionary tale. October 2, 2006

COX-2 inhibitors: A cautionary tale. October 2, 2006 COX-2 inhibitors: A cautionary tale October 2, 2006 Molecular interventions in human disease... An approach as old as human civilization. With whom the herbs have come together Like kingly chiefs unto

More information

CHAPTER 4 PAIN AND ITS MANAGEMENT

CHAPTER 4 PAIN AND ITS MANAGEMENT CHAPTER 4 PAIN AND ITS MANAGEMENT Pain Definition: An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. Types of Pain

More information

IUPAC Name 2-diethylaminoethyl 1- cyclohexylcyclohexane-1- carboxylate Chemical Structure. Molecular Weight

IUPAC Name 2-diethylaminoethyl 1- cyclohexylcyclohexane-1- carboxylate Chemical Structure. Molecular Weight Drug Profile of Dicyclomine Generic Name Dicyclomine IUPAC Name 2-diethylaminoethyl 1- cyclohexylcyclohexane-1- carboxylate Chemical Structure Molecular Weight 309.48 Molecular formula C 19 H 35 NO 2 Melting

More information

EICOSANOID METABOLISM

EICOSANOID METABOLISM 1 EICOSANOID METABOLISM EICOSANOIDS C20 polyunsaturated fatty acids e.g. Arachidonic acid Eicosanoids physiologically, pathologically and pharmacologically active compounds PG Prostaglandins TX - Thromboxanes

More information

Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.

Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes. Reference Guide for PACU Lumbar Fusion CLINICAL PATHWAY All patient variances to the pathway are to be circled and addressed in the progress notes. This Clinical Pathway is intended to assist in clinical

More information

FREQUENTLY ASKED QUESTIONS

FREQUENTLY ASKED QUESTIONS FREQUENTLY ASKED QUESTIONS Frequently Asked Questions: Table of Contents What clinical clues help distinguish between nociceptive and neuropathic pain? Can I combine treatments? Why should the treatment

More information

Can you take ibuprofen and dihydrocodeine together backpage sioux falls dd companies or slogans with alliteration examples

Can you take ibuprofen and dihydrocodeine together backpage sioux falls dd  companies or slogans with alliteration examples Can you take ibuprofen and dihydrocodeine together backpage sioux falls dd companies or slogans with alliteration examples can two puffs fail a tobacco test Brazzers viedos download Sitemap Can I Give

More information

Pain Management Management in Hepatic Hepatic and and Renal Dysfunction

Pain Management Management in Hepatic Hepatic and and Renal Dysfunction Pain Management in Hepatic and Renal Dysfunction Review the pharmacologic basis for medications used in pain management Identify pain medications which hshould ldbe avoided in patients with hepatic dysfunction

More information

Characteristics of selective and non-selective NSAID use in Scotland

Characteristics of selective and non-selective NSAID use in Scotland Characteristics of selective and non-selective NSAID use in Scotland Alford KMG 1, Simpson C 1, Williams D 2 1 Department of General Practice & Primary Care, The University of Aberdeen. 2 Department of

More information

Nonsteroidal Anti-Inflammatory Drugs for Postoperative Pain A Focus on Children

Nonsteroidal Anti-Inflammatory Drugs for Postoperative Pain A Focus on Children REVIEW ARTICLE Pediatr Drugs 2003; 5 (2): 103-123 1174-5878/03/0002-0103/$30.00/0 Adis International Limited. All rights reserved. Nonsteroidal Anti-Inflammatory Drugs for Postoperative Pain A Focus on

More information

CONCERNED ABOUT TAKING OPIOIDS AFTER SURGERY?

CONCERNED ABOUT TAKING OPIOIDS AFTER SURGERY? CONCERNED ABOUT TAKING OPIOIDS AFTER SURGERY? ASK YOUR DOCTOR ABOUT EXPAREL FOR LONG-LASTING, NON-OPIOID PAIN RELIEF. VISIT EXPAREL.com/patient FOR MORE INFORMATION. YOU HAVE A SAY IN HOW YOUR PAIN IS

More information

Pronaxen 250 mg tablet OTC , Version 1.3 PUBLIC SUMMARY OF THE RISK MANAGEMENT PLAN

Pronaxen 250 mg tablet OTC , Version 1.3 PUBLIC SUMMARY OF THE RISK MANAGEMENT PLAN Pronaxen 250 mg tablet OTC 25.9.2015, Version 1.3 PUBLIC SUMMARY OF THE RISK MANAGEMENT PLAN VI.2 Elements for a Public Summary VI.2.1 Overview of disease epidemiology Pronaxen 250 mg is indicated for

More information

Accounting for cardiovascular risk when prescribing NSAIDs

Accounting for cardiovascular risk when prescribing NSAIDs MEDICINES OPTIMISATION Accounting for cardiovascular risk when prescribing NSAIDs DAVID LAIGHT It is now recognised that oral NSAIDs can increase the risk of cardiovascular events, including myocardial

More information

Ali Jaber, Ph.D. MS in Pharmacy MS in Pharmaceutical Chemistry

Ali Jaber, Ph.D. MS in Pharmacy MS in Pharmaceutical Chemistry Nonsteroidal antiinflammatory drugs (NSAID) Ali Jaber, Ph.D. MS in Pharmacy MS in Pharmaceutical Chemistry The inflammatory response occurs in vascularised tissues in response to injury. It is part of

More information

Nerve Blocks & Long Acting Analgesia for Plastic Surgeons. Karol A Gutowski, MD, FACS

Nerve Blocks & Long Acting Analgesia for Plastic Surgeons. Karol A Gutowski, MD, FACS Nerve Blocks & Long Acting Analgesia for Plastic Surgeons Karol A Gutowski, MD, FACS Disclosures None related to this topic Why is Non-Opioid Analgesia Important Opioid epidemic Less opioid use Less PONV

More information

eappendix A. Opioids and Nonsteroidal Anti-Inflammatory Drugs

eappendix A. Opioids and Nonsteroidal Anti-Inflammatory Drugs eappendix A. Opioids and Nonsteroidal Anti-Inflammatory Drugs Nonsteroidal Anti-Inflammatory Drugs Nonselective nonsteroidal anti-inflammatory drugs Diclofenac, etodolac, flurbiprofen, ketorolac, ibuprofen,

More information

Drug Use Criteria: Cyclooxygenase-2 Inhibitors

Drug Use Criteria: Cyclooxygenase-2 Inhibitors Texas Vendor Program Use Criteria: Cyclooxygenase-2 Inhibitors Publication History Developed January 2002. Revised May 2016; October 2014; February 2013; December 2012; March 2011; January 2011; October

More information

Effect of steroid in local infiltrative analgesia in one-stage bilateral total knee arthroplasty. A paired-randomized controlled study

Effect of steroid in local infiltrative analgesia in one-stage bilateral total knee arthroplasty. A paired-randomized controlled study Effect of steroid in local infiltrative analgesia in one-stage bilateral total knee arthroplasty. A paired-randomized controlled study Vincent Chan 1, Chan PK 1, Chiu KY 1, Yan CH 1, FU CH 1, Chan CW 2

More information

Impact of Intravenous Acetaminophen on Reducing Opioid Use After Hysterectomy

Impact of Intravenous Acetaminophen on Reducing Opioid Use After Hysterectomy Impact of Intravenous Acetaminophen on Reducing Opioid Use After Hysterectomy Brittany O. Herring,* Sheila Ader,* Angel Maldonado, Carla Hawkins, Margaretta Kearson, and Madeline Camejo Pharmacy Department,

More information

RISK MANAGEMENT PLAN (RMP) PUBLIC SUMMARY ETORICOXIB ORION (ETORICOXIB) 30 MG, 60 MG, 90 MG & 120 MG FILM-COATED TABLET DATE: , VERSION 1.

RISK MANAGEMENT PLAN (RMP) PUBLIC SUMMARY ETORICOXIB ORION (ETORICOXIB) 30 MG, 60 MG, 90 MG & 120 MG FILM-COATED TABLET DATE: , VERSION 1. RISK MANAGEMENT PLAN (RMP) PUBLIC SUMMARY ETORICOXIB ORION (ETORICOXIB) 30 MG, 60 MG, 90 MG & 120 MG FILM-COATED TABLET DATE: 07-10-2016, VERSION 1.2 VI.2 Elements for a Public Summary Etoricoxib Orion

More information

Risk Management Plan Etoricoxib film-coated tablets

Risk Management Plan Etoricoxib film-coated tablets VI.2 Elements for a Public Summary VI.2.1 Overview of disease epidemiology Osteoarthritis (OA): OA is a condition in which the cartilage of the joints is broken down. This causes stiffness, pain and leads

More information

Conflict of Interest. Background. Objectives. Adverse Events 10/20/2015

Conflict of Interest. Background. Objectives. Adverse Events 10/20/2015 Utilizing a Structured Pain Management Approach in Total Hip and Total Knee Arthroplasty Jennifer Watson, Medication Safety Pharmacist Gina Anderson-Malum, Total Joint Specialist, Bone & Joint Center Conflict

More information

OAA Survey 156: Current prescribing practices for post-operative analgesia following emergency and elective LSCS

OAA Survey 156: Current prescribing practices for post-operative analgesia following emergency and elective LSCS OAA Survey 56: Current prescribing practices for post-operative analgesia following emergency and elective LSCS Janis M Ferns, Jennifer Lambert, Dharshini Radhakrishnan 2. Specialty Trainee, Barts and

More information

Managing Musculoskeletal Pain and Injury

Managing Musculoskeletal Pain and Injury Managing Musculoskeletal Pain and Injury New & Old Drugs: Best Choices MAY 5, 2017 WILLIAM KNOPP, MD Dr. Knopp indicated no potential conflict of interest to this presentation. He does not intend to discuss

More information